1.
Ann Rheum Dis
; 79(6): e71, 2020 06.
Article
in English
| MEDLINE
| ID: mdl-31040120
Subject(s)
Arthritis, Rheumatoid , Fabry Disease , Rheumatology , Humans , Rheumatologists , alpha-Galactosidase
2.
Ann Rheum Dis
; 79(5): e59, 2020 05.
Article
in English
| MEDLINE
| ID: mdl-30755415
Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunology , Antibodies, Antineutrophil Cytoplasmic/immunology , Immunosuppressive Agents/administration & dosage , Precision Medicine/trends , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis , Antibodies, Antineutrophil Cytoplasmic/drug effects , Cyclophosphamide/administration & dosage , Cyclophosphamide/adverse effects , Drug Therapy, Combination , Female , Forecasting , Glucocorticoids/administration & dosage , Humans , Male , Mycophenolic Acid/administration & dosage , Mycophenolic Acid/adverse effects , Patient Safety , Randomized Controlled Trials as Topic , Remission Induction , Risk Assessment , Severity of Illness Index , Treatment Outcome
3.
Arthritis Rheumatol
; 72(1): 200-201, 2020 01.
Article
in English
| MEDLINE
| ID: mdl-31403261
4.
Ann Rheum Dis
; 79(2): e19, 2020 02.
Article
in English
| MEDLINE
| ID: mdl-30472653
5.
Dig Liver Dis
; 51(12): 1741-1742, 2019 12.
Article
in English
| MEDLINE
| ID: mdl-31669076
Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , Penicillamine , Renal Insufficiency , Adult , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/chemically induced , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/mortality , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/physiopathology , Autoimmune Diseases/chemically induced , Autoimmunity/drug effects , Chelating Agents/administration & dosage , Chelating Agents/adverse effects , Clinical Deterioration , Fatal Outcome , Female , Hepatolenticular Degeneration/diagnosis , Hepatolenticular Degeneration/drug therapy , Hepatolenticular Degeneration/physiopathology , Humans , Immunologic Tests/methods , Patient Care Management/methods , Penicillamine/administration & dosage , Penicillamine/adverse effects , Renal Insufficiency/etiology , Renal Insufficiency/physiopathology , Renal Insufficiency/therapy
6.
Strategies of Screening for Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy.
Mayo Clin Proc
; 94(8): 1644-1646, 2019 08.
Article
in English
| MEDLINE
| ID: mdl-31378240
Subject(s)
Fabry Disease , alpha-Galactosidase , Cost-Benefit Analysis , Humans , Hypertrophy, Left Ventricular
7.
J Allergy Clin Immunol
; 144(2): 621, 2019 08.
Article
in English
| MEDLINE
| ID: mdl-31056188
8.
Ann Rheum Dis
; 78(9): e99, 2019 09.
Article
in English
| MEDLINE
| ID: mdl-29921573
9.
Arthritis Rheumatol
; 71(4): 651-652, 2019 04.
Article
in English
| MEDLINE
| ID: mdl-30447134
Subject(s)
Connective Tissue Diseases , Lung Diseases, Interstitial , Pulmonary Medicine , Rheumatology , Humans
10.
Ann Rheum Dis
; 78(10): e111, 2019 10.
Article
in English
| MEDLINE
| ID: mdl-30061162